Women's experience of telehealth cancer genetic counseling.
Telegenetics offers an alternative model of delivering genetic counseling to rural and outreach areas; however there is a dearth of qualitative research into the patient's experience. Twelve women who had received telemedicine genetic counseling for hereditary breast and/or ovarian cancer (HBOC) within the previous 12 months participated in a semi-structured telephone interview. The interview explored women's experience with telegenetics, satisfaction, perceived advantages and disadvantages and quality of the interaction with their genetic professionals. Overall women were highly satisfied with telegenetics. Telegenetics offered them convenience and reduced travel and associated costs. The majority of women described feeling a high degree of social presence, or rapport, with the off-site genetic clinician. One woman with a recent cancer diagnosis, reported that telemedicine was unable to meet her needs for psychosocial support. This finding highlights the need to be mindful of the psychosocial support needs of women with a recent diagnosis being seen via telegenetics. Patients attending for HBOC genetic counseling are generally highly satisfied with the technology and the interaction. Care should be taken, however, with patients with more complex psychosocial needs.
Zilliacus
Elvira M
EM
Department of Medical Oncology, Prince of Wales Hospital, Randwick, NSW, Australia. Elvira.Zilliacus@sesiahs.health.nsw.gov.au
Meiser
Bettina
B
Lobb
Elizabeth A
EA
Kirk
Judy
J
Warwick
Linda
L
Tucker
Katherine
K
D001943:Breast Neoplasms / Q000235:genetics / Q000523:psychology*; D005260:Female; D005817:Genetic Counseling / Q000379:methods*; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics / Q000523:psychology*; D017060:Patient Satisfaction; D017216:Telemedicine; D014930:Women / Q000523:psychology*
J Telemed Telecare. 2000;6(2):73-82
10824374
J Telemed Telecare. 2000;6(4):245-7
11027129
J Telemed Telecare. 1999;5 Suppl 1:S100-2
10534861
BMJ. 2000 May 6;320(7244):1252-6
10797038
J Telemed Telecare. 2004;10(1):29-33
15006213
Health Psychol. 2009 Jan;28(1):11-19
19210013
J Telemed Telecare. 1998;4(1):36-40
9640708
J Telemed Telecare. 2001;7 Suppl 2:68-70
11747665
J Genet Couns. 2009 Dec;18(6):598-605
19798555
Soc Sci Med. 1998 Dec;47(11):1653-8
9877335
Telemed J. 1995 Spring;1(1):41-6
10165321
JAMA. 2004 Jul 28;292(4):442-52
15280342
J Telemed Telecare. 2008;14(4):169-72
18534948
Telemed J. 1998 Winter;4(4):363-9
10220477
J Telemed Telecare. 1997;3(2):63-70
9206275
Genet Med. 2005 Jan;7(1):21-7
15654224
J Behav Med. 2004 Aug;27(4):373-92
15559734
Arch Dermatol. 1998 Apr;134(4):471-6
9554300
J Genet Couns. 2006 Jun;15(3):199-205
16779676
BMJ. 2000 Jun 3;320(7248):1517-20
10834899
Telemed J E Health. 2010 Apr;16(3):350-7
20406122
J Genet Couns. 2005 Jun;14(3):197-206
15959651
J Postgrad Med. 2005 Oct-Dec;51(4):294-300
16388172
J Genet Couns. 2009 Oct;18(5):447-63
19462222
J Telemed Telecare. 2000;6(1):36-40
10824389
J Telemed Telecare. 2000;6(5):285-90
11070590
Am J Med Genet A. 2004 Nov 15;131(1):36-41
15389697
Pediatrics. 2000 Apr;105(4 Pt 1):843-7
10742330
J Genet Couns. 1997 Mar;6(1):21-43
11660391
Eur J Cancer. 2005 Oct;41(15):2257-61
16176873
J Genet Couns. 2003 Apr;12(2):171-84
26140847
J Prof Nurs. 2002 Nov-Dec;18(6):311-2
12486636
Qual Health Res. 2004 Oct;14(8):1046-57
15359042
J Telemed Telecare. 1999;5(4):237-41
10829374
J Telemed Telecare. 2002;8(4):226-30
12217106
J Genet Couns. 2000 Jun;9(3):219-35
26141318
J Genet Couns. 2007 Apr;16(2):211-22
17279329
J Telemed Telecare. 2002;8(4):217-21
12217104
Clin Genet. 2005 Apr;67(4):303-13
15733266
Genet Test. 2008 Mar;12(1):37-52
18373403
Am J Med Genet A. 2005 Apr 1;134A(1):66-73
15690408
Can J Psychiatry. 1986 Feb;31(1):32-4
3512068
Semin Oncol. 2007 Oct;34(5):369-78
17920890
J Telemed Telecare. 2001;7(3):155-60
11346475